Grading of Multifocal Prostate Cancer Cases in which the Largest Volume and the Highest Grade Do Not Coincide within One Lesion.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 6 4 2021
medline: 27 7 2021
entrez: 5 4 2021
Statut: ppublish

Résumé

In general, the index lesion of prostate cancer has the largest tumor volume, the highest Grade Group (GG), and the highest stage (concordant cases). However, these factors sometimes do not coincide within one lesion (discordant cases). In such discordant cases, the largest tumor may not be of biological significance and the secondary tumor may more greatly impact the prognosis. We retrospectively reviewed the medical records of patients who underwent radical prostatectomy, and we identified 580 (85.3%) concordant cases and 100 (14.7%) discordant cases. The end point of this study was biochemical recurrence, and median followup was 4.2 years. Among discordant cases in which GGs of the largest tumor and the highest GG tumor differed, the majority (67 patients) had the largest tumor of GG 2, and we set them as the study cohort. On the other hand, we regarded 212 concordant cases with an index tumor of GG 2 as the control cohort. The study cohort comprised 48 (71.6%) patients with a secondary tumor of GG 3 and 19 (28.4%) with a secondary tumor of GG 4/5. Kaplan-Meier curves revealed that the 5-year biochemical recurrence-free survival rates were 76%, and 67%, respectively. The 5-year biochemical recurrence-free survival rate of the control cohort was 91%, which was significantly better than that of the study cohort (p=0.013 and p=0.014, respectively). Our study suggests that the prognosis of discordant cases is better determined by the secondary cancer lesion with the highest GG instead of the largest lesion.

Identifiants

pubmed: 33818138
doi: 10.1097/JU.0000000000001765
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

338-345

Auteurs

Kazuhiro Matsumoto (K)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Minami Omura (M)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Toshikazu Takeda (T)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Takeo Kosaka (T)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Akinori Hashiguchi (A)

Department of Pathology, Keio University School of Medicine, Tokyo, Japan.

Kimiharu Takamatsu (K)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Yota Yasumizu (Y)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Nobuyuki Tanaka (N)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Shinya Morita (S)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Ryuichi Mizuno (R)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Hiroshi Asanuma (H)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Mototsugu Oya (M)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH